Abstract:Cerebral ischemia (stroke) triggers a complex series of biochemical and molecular mechanisms that impairs the neurologic functions through breakdown of cellular integrity mediated by excitotoxic glutamatergic signalling, ionic imbalance, free-radical reactions, etc. These intricate processes lead to activation of signalling mechanisms involving calcium/calmodulin-dependent kinases (CaMKs) and mitogen-activated protein kinases (MAPKs) such as extracellular signal-regulated kinase (ERK), p38, and c-Jun N-terminal kinase (JNK). The distribution of these transducers bring them in contact with appropriate molecular targets leading to altered gene expression, e.g. ERK and JNK mediated early gene induction, responsible for activation of cell survival/damaging mechanisms. Moreover, inflammatory reactions initiated at the neurovascular interface and alterations in the dynamic communication between the endothelial cells, astrocytes and neurons are thought to substantially contribute to the pathogenesis of the disease. The damaging mechanisms may proceed through rapid nonspecific cell lysis (necrosis) or by active form of cell demise (apoptosis or necroptosis), depending upon the severity and duration of the ischemic insult. A systematic understanding of these molecular mechanisms with prospect of modulating the chain of events leading to cellular survival/damage may help to generate the potential strategies for neuroprotection. This review briefly covers the current status on the molecular mechanisms of stroke pathophysiology with an endeavour to identify potential molecular targets such as targeting postsynaptic density-95 (PSD-95)/N-methyl-d-aspartate (NMDA) receptor interaction, certain key proteins involved in oxidative stress, CaMKs and MAPKs (ERK, p38 and JNK) signalling, inflammation (cytokines, adhesion molecules, etc.) and cell death pathways (caspases, Bcl-2 family proteins, poly (ADP-ribose) polymerase-1 (PARP-1), apoptosis-inducing factor (AIF), inhibitors of apoptosis proteins (IAPs), heat shock protein 70 (HSP70), receptor interacting protein (RIP), etc., besides targeting directly the genes itself. However, selecting promising targets from various signalling cascades, for drug discovery and development is very challenging, nevertheless such novel approaches may lead to the emergence of new avenues for therapeutic intervention in cerebral ischemia.

Understanding the role of cGAS-STING signaling in ischemic stroke: a new avenue for drug discovery

Novel insight into cGAS-STING pathway in ischemic stroke: from pre- to post-disease

The cGAS-STING pathway in ischemia-reperfusion injury in acute cerebral infarction: a new therapeutic opportunities?

Mechanism and therapeutic potential of targeting cGAS-STING signaling in neurological disorders

Inhibition of the cGAS-STING pathway: contributing to the treatment of cerebral ischemia/reperfusion injury

cGAS knockdown promotes microglial M2 polarization to alleviate neuroinflammation by inhibiting cGAS-STING signaling pathway in cerebral ischemic stroke

Blocking Cgas-Sting Pathway Promotes Post-Stroke Functional Recovery in an Extended Treatment Window Via Facilitating Remyelination

The role of STING signaling in central nervous system infection and neuroinflammatory disease

The cytosolic DNA‐sensing cGAS–STING pathway in neurodegenerative diseases

Signaling Pathways in Brain Ischemia: Mechanisms and Therapeutic Implications.

The Cgas-Sting Pathway Drives Neuroinflammation and Neurodegeneration Via Cellular and Molecular Mechanisms in Neurodegenerative Diseases

Emerging role of STING signalling in CNS injury: inflammation, autophagy, necroptosis, ferroptosis and pyroptosis

The cGAS-STING Pathway: A New Therapeutic Target for Ischemia-Reperfusion Injury in Acute Myocardial Infarction?

Exploring the nexus of cGAS STING pathway in neurodegenerative terrain: A therapeutic odyssey

Activating cGAS–STING axis contributes to neuroinflammation in CVST mouse model and induces inflammasome activation and microglia pyroptosis

Stimulator of interferon genes (STING): Key therapeutic targets in ischemia/reperfusion injury

STING inhibition suppresses microglia-mediated synapses engulfment and alleviates motor functional deficits after stroke

The cGAS-STING pathway in cardiovascular diseases: from basic research to clinical perspectives

cGAS-STING-mediated IFN-I Response in Host Defense and Neuroinflammatory Diseases

Molecular targets in cerebral ischemia for developing novel therapeutics

mtDNA-STING Axis Mediates Microglial Polarization via IRF3/NF-κB Signaling After Ischemic Stroke